Financhill
Back

Biolase 10K Form

Sell
9

BIOLQ
Biolase

Last Price:
0.0100
Seasonality Move:
11.03%

7 Day Trial

ALL ACCESS PASS

$ 7

Key Filings

10K form not available

Receive BIOLQ News And Ratings

See the #1 stock for the next 7 days that we like better than BIOLQ

BIOLQ Financial Statistics

Sales & Book Value

Annual Sales: $49.16M
Cash Flow: $-761K
Price / Cash Flow: 0
Annual Sales: $-0.13
Price / Book: 0

Profitability

EPS (TTM): -10.86200
Net Income (TTM): $-19.2M
Gross Margin: $16.72M
Return on Equity: -21668.17%
Return on Assets: -53.78%

Biolase Earnings Forecast

Key Biolase Financial Ratios

  • The Gross Profit Margin over the past 4 years for BIOLQ is 34.02%.
  • The Selling, General & Administrative Expenses for BIOLQ have been equal to 58.29% of Gross Profit Margin.
  • The Research & Development expenses have been 12.21% of Revenue.
  • The Interest Expense is -11.44% of Operating Income.
  • The Net Earning history of BIOLQ is -41.97% of Total Revenues.
  • Per Share Earnings over the last 4 years have been positive in 2 years.

Biolase Stock Price Chart

Industry, Sector and Symbol

Stock Exchange: OTCM
Industry: Health Care Equipment & Supplies
Sector: Health Care
Current Symbol: BIOLQ
Website: biolase.com

Debt

Debt-to-Equity Ratio: -3.1
Current Ratio: 0.71
Quick Ratio: 0.32

Price-to-Earnings

Trailing P/E Ratio: 0
Forward P/E Ratio: 0

BIOLQ Technical Analysis vs Fundamental Analysis

Sell
9
Biolase (BIOLQ) is a Sell

Is Biolase a Buy or a Sell?

  • Biolase stock is rated a Sell
    The current Biolase [BIOLQ] share price is $0.0075. The Score for BIOLQ is 9, which is 82% below its historic median score of 50, and infers higher risk than normal.